Evaluation of the efficacy of daclatasvir+asunaprevir+beclabuvir for Japanese hepatitis C patients; a prospective study in real life settings.
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Apr 2017 New trial record